The expression profile of CDC20, CDKN2A, CTSV, FOXM1, KRT23, MAGEA6, and S100A9 were significantly higher in bladder cancer specimens compared with normal bladder tissue in patients (Figure 5). This evidence concerns the gene KRT23 and urinary bladder carcinoma.